Rituximab (anti-CD20 monoclonal antibody) as single first-line therapy for patients with follicular lymphoma with a low tumor burden: clinical and molecular evaluation.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples